Leaderboards/Asthma and respiratory diseases

Asthma and respiratory diseases

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Laura Schaupp
Humboldt-Universität zu Berlin
2
Annemie Deiteren
Sanofi (Belgium)
3
Baichao Yu
Fudan University
4
Maude A. Liegeois
University of California, San Francisco
5
Régis Joulia
Lung Institute
6
Thomas Plum
German Cancer Research Center
7
Robert Greig
University of Dundee
8
Xiaotian Ju
Wuhan University of Technology
9
Lee Hatter
Victoria University of Wellington
10
JiaSheng Yuan
Nanchang University

Papers

1
Publication in Clinical and Translational Science (2024) [40 citations, W4400014003]
Clinical and Translational Science|2024
40 cit.
2
Publication in European Respiratory Journal (2025) [33 citations, W4406984242]
European Respiratory Journal|2025
33 cit.
3
PM2.5 exacerbates nasal epithelial barrier dysfunction in allergic rhinitis by inducing NLRP3-mediated pyroptosis via the AhR/CYP1A1/ROS axis
Journal of Hazardous Materials|2025
26 cit.
4
Publication (2024) [1 citation, W4404101502]
Unknown Journal|2024
1 cit.
5
Publication in Journal of Cystic Fibrosis (2024) [W4399432676]
Journal of Cystic Fibrosis|2024
0 cit.
6
Publication in Journal of Cystic Fibrosis (2024) [W4402234211]
Journal of Cystic Fibrosis|2024
0 cit.
7
Publication in Journal of Cystic Fibrosis (2025) [W4410996163]
Journal of Cystic Fibrosis|2025
0 cit.
8
Publication in Journal of Cystic Fibrosis (2025) [W4414716442]
Journal of Cystic Fibrosis|2025
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Leif Erik Sander
Humboldt-Universität zu Berlin
2
Zhan Su
Chengdu University of Traditional Chinese Medicine
3
Thomas Marichal
University of Liège
4
Jamie Orengo
Regeneron (United States)
5
Adam Williams
Northwestern University
6
Biyan Zhang
Singapore Immunology Network
7
Oliver Haworth
Brigham and Women's Hospital
8
Xavier Romero Ros
AstraZeneca (United Kingdom)
9
Leda Mannent
Sanofi (France)
10
Loems Zeigler-Heitbrock
Helmholtz Zentrum München

Papers

1
MafB-restricted local monocyte proliferation precedes lung interstitial macrophage differentiation
Nature Immunology|2023
112 cit.
2
IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline
Cytokine|2022
88 cit.
3
Recruited atypical Ly6G <sup>+</sup> macrophages license alveolar regeneration after lung injury
Science Immunology|2024
52 cit.
4
Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results
Annals of Otology Rhinology & Laryngology|2023
30 cit.
5
IgE plasma cells are transcriptionally and functionally distinct from other isotypes
Science Immunology|2024
29 cit.
6
A therapeutic strategy to target distinct sources of IgE and durably reverse allergy
Science Translational Medicine|2023
28 cit.
7
Journey of monocytes and macrophages upon influenza A virus infection
Current Opinion in Virology|2024
24 cit.
8
TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells
Cell Reports Methods|2023
20 cit.
9
mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines
Vaccines|2022
18 cit.
10
Blocking common γ chain cytokine signaling ameliorates T cell–mediated pathogenesis in disease models
Science Translational Medicine|2023
18 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Peter J. Barnes
Imperial College London
2
Vito Brusasco
University of Genoa
3
Ian Pavord
Oxford BioMedica (United Kingdom)
4
Paul M. O’Byrne
Groote Schuur Hospital
5
Stephen T. Holgate
University of Southampton
6
Kian Fan Chung
Imperial College London
7
Scott T. Weiss
Outcomes Research Consortium
8
Qutayba Hamid
University of Sharjah
9
Sally E. Wenzel
National Jewish Health
10
John V. Fahy
University of California, San Francisco

Papers

1
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
European Respiratory Journal|2013
3.9k cit.
2
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
The Lancet|2012
2.2k cit.
3
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children
BMJ|1995
2k cit.
4
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
American Journal of Respiratory and Critical Care Medicine|2009
1.9k cit.
5
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
New England Journal of Medicine|2009
1.9k cit.
6
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response
The Lancet|2000
1.8k cit.
7
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
American Journal of Respiratory and Critical Care Medicine|2009
1.8k cit.
8
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
The Lancet|2002
1.8k cit.
9
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
New England Journal of Medicine|2014
1.6k cit.
10
Differences in Interleukin-8 and Tumor Necrosis Factor-Alpha in Induced Sputum From Patients With Chronic Obstructive Pulmonary Disease or Asthma
American Journal of Respiratory and Critical Care Medicine|1996
1.4k cit.

Reagents for Asthma and respiratory diseases

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

R and D SystemsEvidence 60

Human UbcH5/UBE2D Polyclonal Ab

Cited in 10 papers
#A-615
View Evidence →
Acris AntibodiesEvidence 60

Mouse Anti-Canine Distemper Virus Monoclonal Antibody, Unconjugated, Clone 39937

Cited in 8 papers
#3CD10-5-4
View Evidence →
Acris Antibodies

Mouse Anti-CD154 / CD40L Monoclonal Antibody, Unconjugated Clone 2A3

Cited in 8 papers
#4CD40-2A3
View Evidence →

🌟 All-Time

Most validated

BD BiosciencesEvidence 64

Siglec-F

Cited in 16 papers
#552126
View Evidence →
Cell Signaling TechnologyEvidence 67

Acetyl-CoA Carboxylase 2 (D5B9) Rabbit Monoclonal Antibody

Cited in 13 papers
#8578$161,351
View Evidence →
Agilent/Dako

Mast Cell Tryptase

Cited in 12 papers
#M7052
View Evidence →